SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
65.00    5.00 (8.33%)
Bid:
64.00
Ask:
66.00
Spread: 2.00 (3.125%)
Market Cap: £51.23m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Board Changes

1 Nov 2023 07:00

RNS Number : 9207R
Hardide PLC
01 November 2023
 

The information contained within this announcement is deemed by Hardide to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. 

 

1 November 2023

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

Board changes

 

Hardide plc, the provider of advanced surface treatment solutions, announces that Philip Kirkham has notified the Board of his intention to step down as Chief Executive of the Company on or before 30 April 2024.

 

During his tenure of 11 years, Phil has led the development of the Hardide business including establishing the Group's two new production facilities in the UK and the USA and diversifying the customer base into the industrial, aerospace and power generation sectors, building on its original successes in oil and gas. Phil will leave a well invested and professional business that provides an excellent platform for future growth.

 

The process of recruiting a successor with experience in relevant sectors has commenced and further announcements will be made as appropriate.

 

The Group also announces the appointment of Matthew Hamblin to the Board as an independent Non-Executive Director with immediate effect. Matt will also become a member of the Remuneration & Nomination Committee and the Audit Committee. Until recently he was Chief Executive Officer at Keronite, an advanced coatings and surface treatment company, where he led its growth into profitability and its subsequent sale to the Curtiss-Wright Corporation in November 2022. Matt has prior experience in a variety of sales and commercial leadership roles and has recently worked with Hardide as an external consultant to identify opportunities and initiatives for accelerating revenue growth, a number of which are already being implemented. He is currently Commercial Vice President of Nyobolt, a high-performance battery and charging technology company.

 

Further information with regard to Matthew Hamblin, as required by Schedule 2(g) of the AIM Rules for Companies, is set out below.

 

Andrew Magson, Non-Executive Chair, commented:

 

"The Board and all at Hardide are hugely indebted to Phil Kirkham for his leadership of the Group for over 11 years and his key role in building the business and platform for growth that we have today. We look forward to continuing to work with Phil in the coming months as we manage the succession to a new CEO. We wish Phil well for the future.

 

"The Group continues to advance its strategy of becoming a sales focused and commercially entrepreneurial business, to accelerate revenue growth and better utilise existing operational capacity. With the business now trading at around EBITDA break even, our aim is to leverage revenue growth to become net cash generative and earnings per share positive as soon as possible, building value for shareholders and other stakeholders.

 

 "We are separately pleased to welcome Matt Hamblin to the Board and we look forward to the contribution that his experience in leading a similar business into profit and beyond through organic revenue growth can make to advancing our strategy."

 

 

Matthew Roger Hamblin (Age 49)

 

Current Directorships:

 

None.

 

Past Directorships in the last 5 years:

 

Keronite Group Limited.

Keronite International Limited.

Keronite Inc.

 

Matthew Hamblin does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Matthew Hamblin required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

 

Enquiries:

Hardide plc

Andrew Magson, Non-Executive Chair

Philip Kirkham, CEO

Jackie Heddle, Communications Manager

 

Tel: +44 (0) 1869 353 830

 

IFC Advisory

Graham Herring

Tim Metcalfe

Florence Chandler

 

Tel: +44 (0) 20 3934 6630

 

Cavendish Capital Markets Ltd - Nominated Adviser and Joint Broker

Henrik Persson/ Abigail Kelly (Corporate Finance)

Barney Hayward (ECM/Broking)

 

Tel: +44 (0) 2072 200 500

 

Allenby Capital - Joint Broker

Tony Quirke/ Joscelin Pinnington - Sales and Corporate Broking

Jeremy Porter/ Dan Dearden-Williams - Corporate Finance

 

 

Tel: +44 (0) 20 3328 5656

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFERIRLLVIV
Date   Source Headline
1st Jun 20263:35 pmRNSHolding(s) in Company
27th May 20267:00 amRNSSignificant further order intake North America
21st May 20267:00 amRNSInterim Statement
5th May 20266:00 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSNew Order Intake and Notice of Interim Results
24th Mar 20264:30 pmRNSResult of AGM
24th Mar 20264:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAGM Trading Statement
20th Mar 20265:05 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSNotice of AGM
17th Mar 20267:00 amRNSNotice of AGM
11th Mar 202610:09 amRNSHolding(s) in Company
11th Mar 202610:09 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSFurther significant North American order intake
13th Feb 202612:03 pmRNSHolding(s) in Company
11th Feb 202611:35 amRNSDirector Dealings
10th Feb 202612:48 pmRNSGrant of Executive Share Options
3rd Feb 20267:00 amRNSSignificant New Order in North America
29th Jan 202611:17 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSAnnual results to 30 September 2025
12th Jan 20267:00 amRNSNotice of Results
1st Dec 20253:03 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSSignificant Orders from a Major New Customer
7th Nov 20258:53 amRNSHolding(s) in Company
24th Oct 20255:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSYear End Trading Update
28th May 20253:00 pmRNSDirector Dealings
27th May 20252:48 pmRNSDirector Dealings
20th May 20257:00 amRNSInterim Statement
18th Mar 20253:30 pmRNSResult of AGM
18th Mar 20257:00 amRNSAGM Trading Statement
4th Feb 20257:00 amRNSDirector Dealings
29th Jan 20257:00 amRNSAnnual results for year ended 30 September 2024
15th Jan 202510:00 amRNSNotice of Results
27th Dec 20247:00 amRNSGrant of Options and Issue of Shares
18th Dec 20247:00 amRNSNew Aerospace Supply Agreement
3rd Dec 20247:00 amRNSBoard Changes
21st Oct 20247:00 amRNSYear End Trading Update
18th Jun 20247:00 amRNSBoard Change and Appointment of Sole Broker
22nd May 20247:01 amRNSInterim Statement
22nd May 20247:00 amRNSAnnouncement of new Chief Executive Officer
8th May 20247:00 amRNSNotice of Results
1st May 202410:27 amRNSHolding(s) in Company
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.